Hey there! Welcome!
Get updated on
stem cell
stem cell
stem cell
Top Picks

calendar
28 Apr, 26
dot
link
ESCMID 2026
Key sessions presented at Congress of the European Society of Clinical Microbiology and Infectious Diseases held at Munich, Germany.

calendar
28 Apr, 26
dot
link
ESCMID 2026
Key sessions presented at Congress of the European Society of Clinical Microbiology and Infectious Diseases held at Munich, Germany.

calendar
6 May, 26
dot
link
Pediatrics
  • Vit C deficiency caused severe PH with RV dysfunction and high NT proBNP in 4 children.
  • Presented with musculoskeletal symptoms or cardiorespiratory failure; scurvy signs aided diagnosis.
  • Vit C therapy led to rapid recovery, complete resolution by 3 months; sildenafil alone ineffective.
  • Important to consider this diagnosis in children with restricted diets and unexplained PH.

calendar
5 May, 26
dot
link
BMC Infect. Dis. 
  • Levofloxacin was effective in 82 children with refractory Mycoplasma pneumoniae pneumonia (RMPP), with rapid fever resolution (1.96 ± 1.52 days).
  • Blood counts remained stable; WBC, neutrophils, platelets unchanged (P > 0.05).
  • AST, LDH, CK‑MB, creatinine, urea decreased after treatment (P < 0.05), indicating no liver/kidney injury.
  • Mild adverse reactions; no serious events or sequelae during 12‑month follow‑up.

calendar
5 May, 26
dot
link
Diabetic Med.
  • In 166 hospitalized T2DM patients on basal-bolus insulin, AKI reduced time in range (TIR) by 7.3%-points, driven by increased time above range, with no TBR change
  • Each 100 μmol/L creatinine rise lowered TIR by 7.6%-points, AKI increased in-hospital mortality ~10-fold, along with ICU referral, & doubled 30-day readmission risk
  • Hyperglycemia is also a key concern that should be addressed in these patients.

calendar
4 May, 26
dot
link
Heart Rhythm.
  • Atrial fibrillation (AF) increases risk of stroke and cognitive decline; in 19,533 participants, cognitive impairment occurred in 27% no AF/no stroke, 41% no AF/stroke, 31% AF/no stroke, 43% AF/stroke (p<0.0001)
  • Females with AF/no stroke had higher risk (HR 1.18), stroke predicted cognitive decline in males with AF (HR 2.33) & without AF (HR 1.65)
  • Sex-specific differences underscore tailored risk stratification.